Loading...
Stryker Corporation
0R2S.L•LSE
Healthcare
Medical - Equipment & Services
£380.40
£-21.11(-5.26%)
Stryker Corporation (0R2S.L) Financial Performance & Income Statement Overview
Analyze Stryker Corporation (0R2S.L) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Revenue Growth
10.23%
↑ 10.23%
Operating Income Growth
-5.12%
↓ 5.12%
Net Income Growth
-5.43%
↓ 5.43%
Operating Cash Flow Growth
14.31%
↑ 14.31%
Operating Margin
15.18%
↑ 15.18%
Gross Margin
64.14%
↑ 64.14%
Net Profit Margin
12.25%
↑ 12.25%
ROE
10.80%
↑ 10.80%
ROIC
9.26%
↑ 9.26%
Stryker Corporation (0R2S.L) Income Statement & Financial Overview
Analyze Stryker Corporation’s 0R2S.L earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.87B | $6.44B | $5.49B | $5.42B |
| Cost of Revenue | $2.12B | $2.26B | $1.98B | $2.10B |
| Gross Profit | $3.74B | $4.17B | $3.52B | $3.32B |
| Gross Profit Ratio | $0.64 | $0.65 | $0.64 | $0.61 |
| R&D Expenses | $405.00M | $369.00M | $377.00M | $352.00M |
| SG&A Expenses | $2.30B | $2.13B | $1.90B | $1.81B |
| Operating Expenses | $2.71B | $3.59B | $2.43B | $2.17B |
| Total Costs & Expenses | $4.83B | $5.86B | $4.41B | $4.26B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $264.00M | $268.00M | $258.00M |
| EBITDA | $837.00M | $1.82B | $1.35B | $1.31B |
| EBITDA Ratio | $0.14 | $0.28 | $0.25 | $0.24 |
| Operating Income | $837.00M | $581.00M | $1.08B | $1.16B |
| Operating Income Ratio | $0.14 | $0.09 | $0.20 | $0.21 |
| Other Income/Expenses (Net) | -$73.00M | -$53.00M | -$42.00M | -$53.00M |
| Income Before Tax | $764.00M | $528.00M | $1.04B | $998.00M |
| Income Before Tax Ratio | $0.13 | $0.08 | $0.19 | $0.18 |
| Income Tax Expense | $110.00M | -$18.00M | $209.00M | $173.00M |
| Net Income | $654.00M | $546.00M | $834.00M | $825.00M |
| Net Income Ratio | $0.11 | $0.08 | $0.15 | $0.15 |
| EPS | $1.71 | $1.43 | $2.19 | $2.17 |
| Diluted EPS | $1.69 | $1.42 | $2.16 | $2.14 |
| Weighted Avg Shares Outstanding | $381.70M | $381.00M | $381.10M | $381.00M |
| Weighted Avg Shares Outstanding (Diluted) | $386.40M | $386.10M | $385.60M | $385.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan